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ABSTRACT 
 
In the present study, a master seed, a working seed and an 
experimental batch of the Newcastle disease (ND) Dongola lentogenic strain 
was prepared in embryonated chicken eggs via the allantoic cavity route. 
The embryo infective dose 50 percent end point (EID50/ml) determined in 
chick embryos was found to be 109.2/ml. Experimental trials were designed 
to determine the effect of age, route and dose of vaccine in terms of humoral 
immune response and withstanding challenge with virulent NDV strain. 
Additionally, the study included testing for the safety and immunogenicity 
of this vaccine and comparing it with K and Lasota strains. 
 Three age groups (1day, 1week and 2weeks) were vaccinated by the 
intranasal (I/N) route. The mean haemagglutination inhibition (HI) titres 
among the three age groups at 2 week post vaccination (pv) were 3.4, 4 and 
4.5 (log2), respectively. At 4week pv. The titres were 2.2, 2.7 and 3.2 (log2), 
respectively. On the other hand, percent protections after challenge were 
30%, 40% and 60%, respectively. The % protection among the control 
groups were zero, throughout the experimental course. Accordingly, 
vaccination of 2 week old chicks which gave good immune response and   
protection was chosen in the further experimental trials.  
The administration of Dongola vaccine using drinking water (DW), 
Intranasal (I/N) and Intraocular (I/O) routes resulted in mean HI titres of   
4.9 and 3.6 (DW); 5 and 4 (I/N); 5.2 and 4.1 (log2) (I/O) 2 weeks and 4 
weeks pv, respectively. In addition, percent protections after challenge were 
70%, 80% and 85%, respectively. The intraocular route was found to be 
superior to the intranasal which was better than the drinking water route. 
 xiv
Using different doses (half, recommended, double and 5 times dose) 
of Dongola vaccine by I/N route resulted in mean HI titres (log2) of 3.4 and 
2.4 (1/2 dose); 4.6 and 2.9 (recommended dose); 4.8 and 3.4 (double dose); 
6.4 and 3.4 (5 times dose) 2 weeks and 4 weeks pv, respectively. On the 
other hand, percent protections after challenge were 30%, 50%, 70% and 
70%, respectively. Using of double the dose and 5 times recommended dose 
gave good immune response without any post vaccination reaction, so 
Dongola vaccine was absolutely safe. 
The vaccination of two weeks old chicks by the I/N route with 
Dongola strain in comparison with Lasota and K strain resulted in mean HI 
titres (log2) 2 weeks and 4 weeks pv of 3.1 and 1.8 (Lasota); 4.6 and 2.8 
(Dongola); 5.6 and 3.9 (K), respectively. On the other hand, percent 
protections after challenge were 20%, 50% and 80%, respectively. 
The increase of mean HI titres 2 weeks after vaccination was observed 
in all experiments then it decreased 4 weeks after vaccination, therefore the 
booster dose was recommended.      
It was recommended that a vaccine can be produced from Dongola 
strain in embryonated eggs to be used via the intraocular route at the age of 
two weeks in the Sudan. 
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 ﻣﻠﺨﺺ اﻷﻃﺮوﺣﺔ
 
ودﻓﻌﺔ )dees gnikrow(  ؛ ﺑﺎدﺋﺔ ﻋﺎﻣﻠﺔ ) dees retsam(ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ ﺗﻢ ﺗﺤﻀﻴﺮ ﺑﺎدﺋﺔ رﺋﻴﺴﻴﺔ 
ﻟﻤﺮض اﻟﻨﻴﻮآﺎﺳﻞ  ( alognoD) ﻣﻦ اﻟﻌﺘﺮة ﺧﻔﻴﻔﺔ اﻟﻀﺮاوة دﻧﻘﻼ )hctab latnemirepxe( ﺔﺗﺠﺮﻳﺒﻴ
ﺠﺮﻋﺔ اﻟﺨﻤﺠﻴﺔ ﻓﻲ ﺗﻤﺖ ﻣﻌﺮﻓﺔ اﻟ, . ﻓﻲ أﺟﻨﺔ اﻟﺒﻴﺾ اﻟﻨﺎﻣﻲ ﻋﻦ ﻃﺮﻳﻖ اﻟﺤﻘﻦ ﻓﻰ اﻟﺘﺠﻮﻳﻒ اﻟﺴﻘﺎﺋﻰ
ﻃﺮﻳﻘﺔ اﻹﻋﻄﺎء , آﻤﺎ ﺗﻢ إﺟﺮاء اﻟﺘﺠﺎرب ﻟﻤﻌﺮﻓﺔ ﺗﺄﺛﻴﺮ ﻋﻤﺮ اﻟﻜﺘﺎآﻴﺖ, ﻣﻞ /2.901  وهﻲ05DIEاﻷﺟﻨﺔ 
. واﻟﺠﺮﻋﺔ ﻋﻠﻰ اﻟﻤﻨﺎﻋﺔ اﻟﺴﻮاﺋﻠﻴﺔ وﻣﻘﺎوﻣﺔ ﺟﺮﻋﺔ اﻟﺘﺤﺪي ﺑﻌﺘﺮة ﺷﺪﻳﺪة اﻟﻀﺮاوة ﻟﻔﻴﺮوس اﻟﻨﻴﻮآﺎﺳﻞ
وﻻﺳﻮﺗﺎ  ( K)ﺎح آﺎﻣﻮروف ﺑﺎﻻﺿﺎﻓﺔ اﻟﻲ ﻣﻌﺮﻓﺔ اﻟﻤﻘﺪرة اﻟﻤﻨﺎﻋﻴﺔ ﻟﻠﻘﺎح وﺳﻼﻣﺘﻪ وﻣﻘﺎرﻧﺘﻪ ﺑﻠﻘ
ﺑﻠﻘﺎح دﻧﻘﻼ ( أﺳﺒﻮﻋﺎن, أﺳﺒﻮع , ﻳﻮم )ﺗﻢ ﺗﺤﺼﻴﻦ ﺛﻼث ﻣﺠﻤﻮﻋﺎت ﻋﻤﺮﻳﻪ ﻣﻦ اﻟﺪواﺟﻦ (. atosaL)
ﻣﻦ ﺧﻼل اﻟﺜﻼث ﻣﺠﻤﻮﻋﺎت ( ﻟﻮﻏﺮﻳﺜﻢ)آﺎن ﻣﺘﻮﺳﻂ اﻟﻤﻌﻴﺎر ﻟﻤﻨﻊ اﻟﺘﻼزن اﻟﺪﻣﻮي . ﻋﻦ ﻃﺮﻳﻖ اﻻﻧﻒ
 7.2, 2.2ﺑﻌﺔ أﺳﺎﺑﻴﻊ ﻣﻦ إﻋﻄﺎﺋﻪ وﺑﻌﺪ أر.  ﻋﻠﻲ اﻟﺘﻮاﻟﻲ 5.4 و4 ,4.3ﺑﻌﺪ اﺳﺒﻮﻋﻴﻦ ﻣﻦ اﻋﻄﺎء اﻟﻠﻘﺎح 
. ﻋﻠﻲ اﻟﺘﻮاﻟﻲ% 06و% 04, %03وﻧﺴﺒﺔ اﻟﺤﻤﺎﻳﺔ ﺑﻌﺪ ﺟﺮﻋﺔ اﻟﺘﺤﺪى آﺎﻧﺖ . ﻋﻠﻲ اﻟﺘﻮاﻟﻲ2.3و 
  .اﻟﻨﺴﺒﺔ اﻟﻤﺌﻮﻳﺔ ﻟﻠﺤﻤﺎﻳﺔ ﻟﻠﺪواﺟﻦ ﻏﻴﺮ اﻟﻤﻄﻌﻤﺔ آﺎﻧﺖ ﺻﻔﺮ ﻓﻲ آﻞ اﻟﻤﺠﻤﻮﻋﺎت اﻟﻌﻤﺮﻳﺔ
ﻋﻴﻦ ﻻﺟﺮاء ﺑﺎﻗﻲ      ﺑﻤﺎ أن اﻟﺘﺤﺼﻴﻦ ﻓﻲ ﻋﻤﺮ اﺳﺒﻮﻋﻴﻦ اﻋﻄﻲ اﻓﻀﻞ ﻧﺘﻴﺠﺔ ﻓﻘﺪ اﺧﺘﻴﺮ ﻋﻤﺮ اﺳﺒﻮ
  .اﻟﺘﺠﺎرب
 ﺗﻢ اﺧﺘﺒﺎرهﺎ ﻓﻲ هﺬﻩ اﻟﺘﺠﺮﺑﺔ ﻋﻦ ﻃﺮﻳﻖ ﻣﺎء اﻟﺸﺮب واﻷﻧﻒ واﻟﻌﻴﻦ alognoDﻃﺮﻳﻘﺔ اﻹﻋﻄﺎء ﻟﻠﻘﺎح 
, (اﻷﻧﻒ  )4 , 5,  (ﻣﺎء اﻟﺸﺮب) 6.3 , 9.4آﺎﻟﺘﺎﻟﻲ ( 2ﻟﻮ)آﺎن ﻣﺘﻮﺳﻂ اﻟﻤﻌﻴﺎر ﻟﻤﻨﻊ اﻟﺘﻼزن اﻟﺪﻣﻮي 
 اﻟﻠﻘﺎح  وﻧﺴﺒﺔ اﻟﺤﻤﺎﻳﺔ ﺑﻌﺪ ﺟﺮﻋﺔ اﻟﺘﺤﺪى ﺑﻌﺪ أﺳﺒﻮﻋﻴﻦ و أرﺑﻌﻪ أﺳﺎﺑﻴﻊ ﻣﻦ إﻋﻄﺎء( اﻟﻌﻴﻦ )1.4 ,2.5
وﺟﺪ أن اﻟﺘﺤﺼﻴﻦ ﻋﻦ ﻃﺮﻳﻖ اﻟﻌﻴﻦ اﻓﻀﻞ ﻣﻦ اﻟﺘﺤﺼﻴﻦ . ﻋﻠﻲ اﻟﺘﻮاﻟﻲ% 58و % 08,  %07آﺎﻧﺖ 
  .ﻋﻦ ﻃﺮﻳﻖ اﻷﻧﻒ وهﻮ اﻓﻀﻞ ﻣﻦ اﻟﺘﺤﺼﻴﻦ ﻓﻲ ﻣﺎء اﻟﺸﺮب
ﻣﻦ (  اﺿﻌﺎف اﻟﺠﺮﻋﺔ5, ﺿﻌﻒ اﻟﺠﺮﻋﺔ, اﻟﺠﺮﻋﺔ اﻟﻜﺎﻣﻠﺔ,  اﻟﺠﺮﻋﺔ2/1)اﺳﺘﺨﺪام ﺟﺮﻋﺎت ﻣﺨﺘﻠﻔﺔ 
آﺎن آﺎﻟﺘﺎﻟﻲ ( 2ﻟﻮ) ﻋﻦ ﻃﺮﻳﻖ اﻷﻧﻒ ﻧﺘﺞ ﻋﻨﻪ ﻣﺘﻮﺳﻂ اﻟﻤﻌﻴﺎر ﻟﻤﻨﻊ اﻟﺘﻼزن اﻟﺪﻣﻮي alognoDﻟﻘﺎح 
 4.3, 4.6, (ﺿﻌﻒ اﻟﺠﺮﻋﺔ )4.3 , 8.4, (اﻟﺠﺮﻋﺔ اﻟﻜﺎﻣﻠﺔ )9.2 , 6.4, ( اﻟﺠﺮﻋﺔ2/1 )4.2, 4.3
وﻧﺴﺒﺔ اﻟﺤﻤﺎﻳﺔ ﺑﻌﺪ ﺟﺮﻋﺔ . ﺑﻌﺪ أﺳﺒﻮﻋﻴﻦ و أرﺑﻌﻪ أﺳﺎﺑﻴﻊ ﻣﻦ إﻋﻄﺎء اﻟﻠﻘﺎح ( أﺿﻌﺎف اﻟﺠﺮﻋﺔ5)
اﺳﺘﻌﻤﺎل ﺿﻌﻒ وﺧﻤﺴﺔ أﺿﻌﺎف اﻟﺠﺮﻋﺔ . ﻋﻠﻲ اﻟﺘﻮاﻟﻲ% 07و % 07, %05, %03ﺖاﻟﺘﺤﺪى آﺎﻧ
اﻟﻤﻮﺻﻲ ﺑﻬﺎ أﻋﻄﻰ اﺳﺘﺠﺎﺑﺔ ﻣﻨﺎﻋﻴﺔ ﺟﻴﺪة ﻣﻦ ﻏﻴﺮ أي ﺗﻔﺎﻋﻼت ﻣﺎ ﺑﻌﺪ اﻟﺘﺤﺼﻴﻦ ﻟﻬﺬا ﻳﻌﺘﺒﺮ ﻟﻘﺎح 
  . ﺁﻣﻦ ﺗﻤﺎﻣﺎalognoD
ivx 
 atosaL ﻋﻦ ﻃﺮﻳﻖ اﻷﻧﻒ ﻟﻤﻘﺎرﻧﺘﻪ ﺑﻠﻘﺎﺣﻲ alognoD ﺗﺤﺼﻴﻦ آﺘﺎآﻴﺖ ﻋﻤﺮ أﺳﺒﻮﻋﻴﻦ ﺑﻠﻘﺎح 
ﺑﻌﺪ أﺳﺒﻮﻋﻴﻦ و أرﺑﻌﻪ أﺳﺎﺑﻴﻊ ﻣﻦ ( ﻟﻮﻏﺮﻳﺜﻢ)ﻋﻄﻲ ﻣﺘﻮﺳﻂ ﻣﻌﻴﺎر ﻟﻤﻨﻊ اﻟﺘﻼزن اﻟﺪﻣﻮي  اvoramokو
             9.3,  6.5 ,(alognoD ) 8.2, 6.4 ,(atosaL) 8.1, 1.3 إﻋﻄﺎء اﻟﻠﻘﺎح آﺎﻧﺖ آﺎﻟﺘﺎﻟﻲ
  .ﻋﻠﻲ اﻟﺘﻮاﻟﻲ% 08و % 05, %02وﻧﺴﺒﺔ اﻟﺤﻤﺎﻳﺔ ﺑﻌﺪ ﺟﺮﻋﺔ اﻟﺘﺤﺪى آﺎن (. voramok)
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Introduction 
 
Newcastle disease (ND) is a viral infection of birds, which can cause 
up to 100% mortality in susceptible chickens (Gordan and Jordan, 1982). 
Newcastle disease has a worldwidZW2AZe distribution. It is caused by a 
virus (Avian Paramyxo Virus 1) that belongs to the genus Avulavirus of 
Subfamily Paramyxovirinae of the family Paramyxoviridae (Alexander, 
1997). 
Newcastle disease has a great variation in pathogenicity for chickens. 
Strains of Newcastle disease virus (NDV) have been grouped into five 
pathotypes on the basis of clinical signs. These are viscerotropic velogenic 
(VV), neurotropic velogenic (NV), mesogenic, lentogenic and asymptomatic 
enteric Pathotype (Beard and Hanson, 1984).   
The disease was first reported in the Sudan in 1951 and since then its 
prevalence was authenticated in the annual reports of the Sudan Veterinary 
service. The disease has been reported from all Provinces of the Sudan and 
took a highly virulent form causing heavy mortalities both in indigenous and 
foreign breeds (Karrar and Mustafa, 1964). 
There are three types of commercially available vaccines for 
Newcastle disease: Live lentogenic vaccines, live mesogenic vaccines and 
inactivated vaccines (Alexander, 1990). 
The first vaccination against ND in the Sudan was performed in 1951 
with a vaccine imported from South Africa (Anon., 1951). The Komarov 
strain of NDV, which is a mesogenic strain, has been recognized by the 
Sudan Veterinary Authorities since 1958 as the appropriate vaccine for 
control of ND and is gradually being more widely used (Karrar and Mustafa, 
1964). 
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Mesogenic vaccines are capable of causing severe disease and must 
only be administered following primary vaccination with lentogenic 
vaccines but are capable of producing a high secondary immune response 
(Alexander, 1990). 
Live lentogenic vaccines are usually derived from field viruses which 
have been shown to have low pathogenicity for poultry but produce an 
adequate immune response (Alexander, 1990). 
Three isolates of NDV were obtained from apparently healthy 
chickens in Dongola city (Northern Sudan). These isolates  were considered 
to be lentogenic strains, since they have all the characteristics of lentogenic 
strains and they were grouped in (E) group of paramyxoviruses in close 
relation to Lasota strain (Khalafalla, 1994). 
The aims of this study are: 
 1) To produce a vaccine from one of these local lentogenic strains 
(Dongola) by passages in embryonated eggs. 
2) To test for the efficacy of this vaccine and to determine the best dose, 
route and age for vaccination in layer chicks. 
3) To compare this vaccine with Komarov and Lasota vaccines in term of 
immune response and protection of vaccinated chicks. 
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CHAPTER 1 
LITERATURE REVIEW 
 
1.1. Definition 
Newcastle disease (ND) is a highly contagious paramyxo virus-1 
infection of poultry and has devastating effect on economical poultry 
production (Alexander, 1980). 
Murphy et al (1999) defined ND as the most important disease of 
poultry worldwide eversince the advent of high density, confinement 
husbandry system. 
1.2. History 
The first outbreak of ND occurred in Java, Indonesia in 1926 
(Kraneveld, 1926). In the same year it spread to England (Doyle, 1927). 
 
1.3. Newcastle disease virus (NDV)  
1.3.1. Classification 
ND is caused by specified viruses of the Avian paramyxovirus type-1 
(APMV-1) serotype of the genus Avulavirus belonging to the subfamily 
Paramyxovirinae of family paramyxoviridae.The paramyxoviruses isolated 
from avian species have been classified by serological testing into 9-
serotypes designated APMV-1 to APMV-9 (Alexander, 1997).The family 
paramyxoviridae is subdivided into the subfamilies Paramyxovirinae and 
Pneumovirinae, the former containing the genera Respirovirus, Rubulavirus, 
and Morbillivirus, Pneumovirinae containing genera Pneumovirus and 
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Metapneumovirus (Murphy et al., 1999). Paramyxoviridae, Rhabdoviridae, 
Filoviridae and Bornaviridae form the order Mononegavirales. All members 
of these families are enveloped, covered with peplomers and all have 
genomes consisting of a single molecule of Negative- sense, single stranded 
RNA (Murphy et al., 1999). 
1.3.2. Virion properties 
Paramyxovirus virions are pleomophic in shape (spherical as well as 
filamentous forms occur), 150-300 nm in diameter. Virions are enveloped, 
covered with large peplomers (8-20 nm in length), and contain “a herring 
bone-shaped” helically symmetrical neuclocapsid, 600-800 nm in length and 
18 (Paramyxovirus, Rubulavirus, Morbillivirus) or 13 (Pneumovirus) nm in 
diameter. The genome consists of single-linear molecule of negative-sense 
single-stranded RNA, 15-16 kb in size (Murphy et al., 1999). 
1.4. Viral Replication 
NDV replicate within the cytoplasm. Virions attach via their 
haemagglutinin-neuraminidase protein to cellular sialoglyco protein or 
glycolipid receptors. The fusion protein then mediates fusion of the viral 
envelope with the plasma membrane at physiological pH (Murphy et al., 
1999). Because the viral RNA has negative- sense, it is necessary for the 
viral RNA directed RNA Polymerase (transcriptase) to produce 
complementary transcripts of positive- sense that may act as messenger 
RNA and utilize the cell’s mechanism enabling translation into protein and 
virus progeny (Alexander, 1991). The fusion protein synthesized a non-
functional precursor which requires post-translation cleavage to F1&F2 by 
host protease’s (Alexander, 1991). The viral proteins synthesized in an 
infected cell are transported to the cell membrane, which becomes modified 
by their incorporation. Following alignment of the nucleocapsid close to 
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modified regions of the cell membrane virus particles are bubbled from the 
cell surface (Alexander, 1991). 
1.5. Resistance to physical and chemical agents 
 NDV can be inactivated in varying degrees by such physical and 
chemical agents as heat, ultraviolet, pH, oxidation processes, and chemical 
compounds (Lysol, phenol and detergent). It is important to keep in mind 
that the rate of virus inactivation varies with the strain of NDV, quantity of 
virus initially exposed, time of exposure, and presence of organic matter in 
the environment (Yuan, 1999). 
1.6. Strain Classification 
NDV has great variation in pathogenicity for chickens. Strain of NDV 
have been grouped into five pathotypes on the basis of clinical signs, these 
are: 
1-Viscerotropic Velogenic (VVNDV):  This pathotype causes a highly 
pathogenic form in which haemorrhagic intestinal lesion are frequently seen.  
2-Neurotropic Velogenic (NVNDV): This pathotype presents with 
high mortality, usually following respiratory and nervous signs. 
3-Mesogenic NDV: This pathotype presents with respiratory signs, 
occasional nervous signs, but low mortality. 
     4-Lentogenic (Respiratory) NDV: This pathotype presents with mild 
or sub clinical respiratory disease. 
    5- Asymptomatic enteric NDV: This pathotype usually consist of sub 
clinical enteric infection (Beard and Hanson, 1984). 
According to Yuan chungzee (1999) ND takes several different forms 
in chickens, depending on the virulence of the strain involved. The very 
virulent velogenic strains cause very rapidly infection involving visceral 
organs (Doyle’s form) or the central nervous system (CNS) (Beach’s form). 
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Mesogenic strains cause a disease represented by respiratory and, 
occasionally nervous symptoms with low mortality (Beaudette’s form), 
while lentogenic strains produce a mild or often inapparent disease 
(Hitchner’s form). 
1.7. Pathogenesis 
Initially the virus replicates in the mucosal epithelium of the upper 
respiratory and intestinal tracts. Shortly after infection, virus spread via the 
blood to the spleen and bone marrow producing secondary viremia that leads 
to infection of other target organs: lung, intestine, CNS (Murphy et al., 
1999). 
In natural or experimental infection, viral replication occurs at the site of 
initial exposure, followed by primary viremia. Wide spread multiplication of 
virus in cells of parenchymal organs lead to a secondary viremia, which in 
some instances leads to infection of the CNS (Yuan, 1999). 
1.8. Transmission 
In addition to chickens, turkeys, pheasants, guinea fowl, ducks, geese 
and pigeons, a wide range of captive and free ranging semi- domestic and 
free living birds, are susceptible to NDV (Murphy et al., 1999). In birds 
that survive, virus is shed in all secretions and excretions for at least 
4weeks. 
Transmission occurs by direct contact between birds by airborne route 
via aerosols and dust particles and via contaminated feed and water. With 
lentogenic strains, transovarial transmission is important, and infected 
chicks may hatch from virus- containing eggs (Murphy et al., 1999). 
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Cracked or broken infected eggs may serve as a source of virus for 
newly hatched chicks, as may virus-laden feces contaminating the outside 
of eggs. Virus may also penetrate the shell after laying (Williams, 1968). 
 
1.9. Diagnosis 
1.9.1. Clinical signs 
The disease produced following infection with NDV may vary 
considerably with the infecting virus. In addition, the species of birds, the 
immune status, age and conditions under which they are reared may also 
greatly affect the disease signs (Alexander, 1990). 
The highly virulent viruses may produce peracute infections of 
chickens where the first indication of disease is sudden death. Typically, 
disease signs such as depression, prostration, diarrhea, oedema of the 
head and nervous signs may occur, with mortality reaching 100% 
(Alexander, 1990). 
Mesogenic viruses usually cause severe respiratory disease, followed 
by nervous signs, with mortality up to 50% or more. The low virulence 
viruses may cause no disease, or mild respiratory distress for a short time 
in chickens and turkeys (Alexander, 1990). 
1.9.2. Lesions 
No gross lesions are pathognomonic for any form of Newcastle  
 disease (Alexander, 1990). 
The presence of haemorrhagic lesions in intestine of infected chickens has 
been used to distinguish VVND viruses from NVND viruses (Hanson, 
1980). 
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Generally, gross lesions are not observed in the CNS of birds infected with 
NDV, regardless of pathotype (McFerran and McCracken, 1988). 
Viruses causing respiratory disease may induce inflammation of the trachea, 
often with haemorrhages present. The air sacs may also be inflamed and 
appear cloudy and congested (Alexander, 1990). 
1.9.3. Virus isolation    
Specimens taken for NDV isolation always include spleen, feces, 
intestinal contents or cloacal swabs and trachea or tracheal swabs. Other 
specimens taken from carcasses should reflect the clinical signs (Alexander, 
1991). Samples should be placed in phosphate – buffered isotonic saline 
containing antibiotic at pH 7.0-7.4 (Alexander, 1990). 
Embryonated fowl’s eggs at 8 to 10 days of age are the preferred 
method for the isolation of NDV. Haemagglutination (HA) activity in 
bacteria –free fluids may be due to any of the avian paramyxoviruses or 
orthomyxoviruses. NDV may be confirmed by haemagglutination inhibition 
(HI) test using specific NDV antiserum (Alexander, 1990).  
1.10. Serological tests   
 NDV may be used as an antigen in a wide variety of serological tests, 
enabling neutralization or enzyme-linked immuno sorbent assays (ELISA) to 
be used for diagnosis (Alexander, 2004). At present, the HI test is the most 
widely used. Chicken sera rarely give non specific positive reaction in this 
test and any pretreatment of the sera is unnecessary (Alexander, 2004). 
1.11. Pathogenicity tests 
It is necessary to carryout laboratory assessment of the pathogenicity of 
the virus. At present, three in vivo tests are used for this purpose: 
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Mean death time (MDT) in eggs, Intracerebral pathogenicity index (ICPI) 
in day old chicks and Intravenous pathogenicity index (IVPI) in 6 week- 
old chickens (Alexander, 1990). 
1.12. Immunity to NDV 
Chickens infected with NDV produce antibodies (Abs) 6-10 days after 
viral exposure, reaching a peak in 3 to 4 weeks (Yuan, 1999). 
Antibody production is rapid. Haemagglutination inhibiting Ab can be 
detected within 4-6 days of infection and persists for at least 2 years. 
Maternal Abs protects chicks for 3 to 4 weeks after hatching (Murphy et al., 
1999).  
Immunoglobulins (Ig) IgG, IgM are confined to the circulation and  does 
not prevent respiratory infection, locally produced IgA Abs play an 
important role in protection in both the respiratory tract and the intestine 
(Murphy et al., 1999). 
1.13. Control 
Sanitary management to prevent exposure of susceptible chickens to 
NDV is an important aspect of control against the disease (Yuan, 1999). 
Since there is only one serotype of NDV, vaccination is another majer step 
in preventing ND (Yuan, 1999). 
Most countries free of ND have legislation aimed at preventing the 
introduction of disease by infected bird or contaminated produce 
(Alexander, 1990). 
Control can be achieved by good hygiene combined with immunization 
where the disease is endemic (Murphy et al., 1999). 
1.14. ND Vaccines 
NDV used in commercial live virus vaccines fall into two groups: 
lentogenic vaccines, such as Hitchner, B1, Lasota, V4, I2 and F and 
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mesogenic vaccines, such as Roakin, Mukteswar and Komarov. Most live 
virus vaccines are grown in the allantoic cavity of embryonated fowl eggs 
but some, notably mesogenic strains, have been adapted to a variety of tissue 
culture systems (Alexander, 2004). 
Live virus vaccines may be administered to birds by incorporation in the 
drinking water (DW), delivered as a coarse spray, or by intranasal or 
conjunctival instillation. Some mesogenic strains are given by wing-web 
intradermal inoculation (Alexander, 2004). 
Mesogenic vaccines are capable of causing severe disease and must only 
be administered following primary vaccination with lentogenic viruses 
(Alexander, 1990).  
Inactivated vaccines are more expensive than live vaccine, and their use 
entails handling and injecting individual birds. They are from allantoic fluid 
(AF) that is inactivated by the addition of formaldehyde or beta-
propiolactone. This is incorporated into mineral oil emulsion and is 
administered intramuscularly or subcutaneously. Individual birds thus 
receive a standard dose (Alexander, 2004). 
Many different parameters must be considered in devising vaccination 
programmes and these include the disease situation, disease control policies, 
availability of vaccine, maternal immunity, use of other vaccines, presence 
of other organisms, size of flock, climatic condition and past performance of 
vaccination programmes (Alexander, 1990). 
Maternal immunity represents a particular problem in the vaccination 
against ND as it may prevent the effectiveness of Primary vaccination. To 
overcome its effect, birds are either left until 3 to 4 weeks of age or 
vaccinated with live virus at 1 day old by eye drop or coarse spray, followed  
by revaccination at 3 to 4 weeks of age (Alexander, 1990). 
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1.15. ND in Sudan 
ND was first recognized in Khartoum in 1951 (Anon., 1951) and has 
since been reported from all provinces. Diagnosis was mainly based on the 
clinical symptoms and post-mortem lesion as well as general picture of the 
disease. However, it was not until 1964 that ND diagnosis was for the first 
time documented by virus isolation (Karrar and Mustafa, 1964). 
The pathotype of 12 NDV isolates from Sudan was done by Ballouh 
et al (1983). They found that eight of the investigated strains isolated were 
velogenic and four were mesogenic. More studies were done by Haroun et al 
(1992) in the pathotype of four NDVs isolated from outbreaks around 
Shambat village. They found that they were all viscerotropic velogenic. 
According to Khalafalla et al (1992) six isolates of NDV were 
obtained from field outbreaks that occurred during 1988-1991. All isolates 
agglutinated chickens RBCs and their haemagglutinating ability was 
inhibited by a known NDV positive antiserum. The inoculated embryos died 
with Haemorrhages in various organs. All isolates were found to be 
Viscerotropic velogenic. 
Three NDV isolates were obtained from apparently healthy chickens 
in northern Sudan. They had the characteristics of lentogenic strains of 
NDV. They were the first isolates of lentogenic NDV in Sudan (Khalafalla, 
1994).     
 
1.16. ND Vaccines in Sudan   
The first vaccination against ND in the Sudan was performed in 1951 
with vaccine imported from South Africa (Anon., 1951). 
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The Komarov (K) strain of ND vaccine has been recognized by the Sudan 
veterinary authorities since 1958 as the appropriate vaccine for control and is 
gradually being more widely used (Karrar and Mustafa, 1964). 
ND vaccination involves administration of ND vaccine (K) strain at 28 days 
by intranasal route (Ali, 1975). The common practice is to revaccinate the 
chickens at 3.5-4 months of age. K strain was obtained from Lebanon in 
1962 and propagated in chicken embryos to produce a freeze-dried vaccine 
at the Central Veterinary Research Laboratory (CVRL) (Ali, 1978). 
According to Zakia et al (1982) vaccination of chicks from non-vaccinated 
hens with (F) strain by intranasal route in different ages (one-day, one-week, 
two-week and three-week) gave a good immune response and chicks were 
revaccinated intranasally at different ages with (K) strain. The HI antibody 
titres increased in most of the bird. 
According to Kheir, (1992) Vaccination with (K) strain in DW induced Ab 
levels which were lower than levels produced when it was administered by 
intranasal (I/N) route but chickens withstood challenge with virulent NDV. 
 
 
 
 
 
 
 13
CHAPTER2 
MATERIALS AND METHODS 
2.1. VIRUS STRAINS 
2.1.1. Dongola 88/1 strain 
This local isolate of lentogenic NDV was isolated by Khalafalla in 
1988 from apparently healthy chickens in Dongola city of Northern Sudan 
(Khalafalla, 1994).  
2.1.2. Lasota strain 
Lasota vaccine strain was obtained from the Central Veterinary 
Research Laboratory (CVRL), Animal Resources Research Corp., as freeze-
dried ampoules of 500 doses. This virus was used in the present study for 
vaccination of chicks in order to compare Dongola with Lasota and K 
strains. 
2.1.3. Komarov strain 
Komarov strain was obtained from the CVRL as freeze-dried 
ampoules of 400 doses. It was used in the present study for vaccination of 
chicks in order to compare it with Dongola strain and Lasota. 
2.1.4. I2 strain 
Live NDV vaccine containing the lentogenic thermostable I2 strain 
was propagated in CVRL form freeze- dried ampoules containing I2 seed 
virus originally isolated in Australia by Australian Centre for International 
Agriculture Research (ACIAR). It was used in the present study for 
preparation of antigen for HA and HI test. 
2.1.5. Virulent virus  
     Obeid isolate (code No 9096) is a virulent  NDV isolate that was 
originally isolated from an outbreak that occurred at El-Obied Government 
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Poulty Farm during December 1974 and was kindly supplied by Dr. 
AbdelGadir Belal, Department of Viral Vaccine Production (Poultry), 
CVRL. It was used for challenge test. 
2.2. Chicken embryonated eggs 
Embryonated eggs were collected from the poultry farm of the 
Department of Microbiology, Faculty of Vet. Med. U of K and were 
incubated in the incubator (Funki) at37oC. 
2.3. Experimental chicks 
A total of 215 male chicks of Hisex breed were obtained from Coral 
Poultry Farm as one-day old. Chicks were divided into groups and rared in 
special metal cages till the required age. Chicks were vaccinated against IBD 
with D78 live- vaccine (Intervet) by DW route at 3 weeks of age. 
Experimental chicks were used in the present study to determine the 
effect of age, route of administration, dose of the vaccine and in comparison 
of 3 types of vaccines (Dongola, Lasota and Komarov). 
2.4. Preparation and sterilization of glassware 
Glassware like beakers, flasks, pipettes, centrifuge tube, bijou bottles, 
measuring clinders were boiled in water with a detergent for 20 minutes and 
rinsed in running water for five times to remove the detergent completely. 
They were then immersed overnight in distilled water (DW), left to dry and 
sterilized with dry heat at1800c for 2 hours.  
   Dissecting equipment (forceps, scissors and scalpel handles) were 
sterilized after thorough washing by drying heat at 180oC for 30 minutes. 
   Microtiter plates were shaken in a solution of 1% NaoH they were soaked 
in the same solution overnight.  
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The following day, they were rinsed in tap water and soaked in 1% 
hydrochloric acid (HCL) solution for 2 hours. They were then rinsed in four 
changes of de-ionized distilled water (DDW) and left to dry at room 
temperature.  
2.5. Collection of blood 
Chicks used in vaccination trials were sampled for blood by heart 
puncture &from wing vein using disposable syringes and then the blood was 
left overnight at room temperature to clot and then centrifuged at 1000 rpm 
for 10 minuets. Separated serum samples were stored at -200 c till used. 
2.6. Inoculation of embryonated eggs 
The working seed and the experimental batch of Dongola vaccine 
were prepared by inoculation of 9-11 day-old chicken embryonated eggs. 
Embryonated eggs were candled before inoculation in a dark room to check 
for embryo viability. A line was marked around the airsac and a cross was 
made 2-4 mm over the airsac with a pencil. Eggs were then swabbed with 
70% alcohol and a pore was made on the cross. Eggs were then inoculated 
by the allantoic route with sterile disposable 1ml syringes. Each egg 
received 0.1 ml of the inoculum and the pores were sealed with melted 
paraffin wax. Eggs were then incubated at 370c and candled daily to check 
for embryo death for five days. Embryo death during 24 hours of inoculation 
was considered as non-specific and discarded. At day five post inoculation 
(pi), all eggs were chilled at 40c for at least two hours and the allantoic fluid 
(AF) aseptically collected into sterile vials. 
2.7. Preparation of Dongola vaccine 
2.7.1. Master seed 
A freeze-dried ampoule of Dongola 88/1 isolate was reconstituted by 
sterile DW, centrifuged at 1500 rpm/ 10 min and inoculated into 
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embryonated eggs of 9-11days old by allantoic route. Passage of virus was 
done 4 times. 1ml of passage 4 was diluted to 1/10 in PBS and inoculated in 
embryonated eggs via the allantoic route. At day 5 pi, all eggs were chilled 
at 40c for at least two hours and the allantoic fluid (AF) aseptically collected. 
Harvest of each egg was tested for HA, identified by HI test and stored in 
1.5 ml eppendorf tubes at -20 0c as the master seed. 
2.7.2. Working seed 
1ml of master seed was diluted to 1/100 and inoculated in embryonatd 
eggs of 9-11 days old by the allantoic route with dose of 0.1 ml/egg. At day 
5 pi, all eggs were chilled at 40c for at least two hours and the allantoic fluid 
(AF) aseptically collected and harvest of each egg tested for HA and stored 
in 1.5 ml eppendorf tubes at -20 0c as the working seed. 
2.7.3. Experimental batch of the vaccine 
Embryonated eggs were inoculated with a dose of 0.1 ml/egg of the 
working seed and AFs were harvested and stored in eppendorf tubes at-200c. 
Each batch of the vaccine was tested for sterility and freedom from 
contamination according to the OIE Manual of Diagnostic Tests and 
Vaccines.   
 
2.8. Titration of the vaccine 
Ten-fold serial dilutions of the experimental batch of the vaccine were 
prepared in PBS and each dilution inoculated into five 9-11day-old chicken 
embryos via allantoic route with 0.1 ml volume. Embryonated eggs were 
candled daily. The AF was harvested on day 5pi and tested for virus growth  
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by HA and HI tests. The titre was then calculated using the method of Reed 
and Muench (1938). 
 
2.9. Haemagglutination (HA) and haemagglutination inhibition (HI) test 
2.9.1. Preparation of red blood cells (RBCs) suspension 
Blood was collected from the wing vein of healthy 8-10 weeks-old 
chicken into equal volume of Elsever’s solution. The blood was then 
clarified by centrifugation at 1000 rpm for ten minutes. The supernatant was 
discarded and equal volume of sterile NS was added to the packed RBCs and 
then centrifuged at 1000 rpm for ten minutes. This procedure was repeated 
three times and the packed cells were diluted to1:100 for use in HA&HI. 
2.9.2. HA test procedure 
A volume of 0.025 ml of PBS is dispensed into each well of a U-
bottomed micro titre plate. 
Two-fold serial dilutions of 0.025 ml volumes of the virus suspension were 
made across the plate.0.025 ml of 1% (v/v) chicken RBCs is dispensed to 
each well. The solution is mixed by tapping the plate gently. The RBCs were 
then allowed to settle for 30 minutes at room temperature. The HA titre was 
the reciprocal of the last dilution showing haemagglutination. 
2.9.3. Preparation of 4HA unit of the virus 
HA test was performed on undiluted I2 virus suspension. The last well 
showing HA was considered one HA unit and accordingly, the 4 HA unit 
were calculated. The virus suspension was then diluted to contain 4HA units 
per 0.025 ml. 
2.9.4. HI test procedure 
A volume of 0.025 ml of PBS is dispensed into each well of a U-
bottomed micro titre plate. 
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Two-fold serial dilutions of 0.025 ml volumes of the tested sera were made 
across the plate. 4HAU virus/antigen in 0.025 ml volume was added to each 
well and the plate was left for 30 minutes at room temperature for 
antigen/antibody reaction. 0.025 ml of 1% (v/v) chicken RBCs was added to 
each well and, after gentle mixing, the RBCs were allowed to settle for 30 
minutes at room temperature.  The HI titre was the reciprocal of the last 
dilution showing haemagglutination-inhibition. 
2.10. Challenge test 
Vaccinated and control chicks were challenged with El-Obeid isolate 
of NDV. All chicks were challenged with 0.1 ml of virus containing 105.2 
EID50 by I/M route. Challenged chickens were observed daily for 14 days 
after the challenge.  
Postmortem (PM) examinations were done on all birds that died during this period. 
 
2.11. Experimental design 
2.11.1. Effect of age 
Forty one-day old chicks were divided into four groups (A1, A2, A3, 
and A4) of ten chicks each. Chicks in A1, A2, and A3 were vaccinated at 
1day-old, 1, 2 weeks of age with 0.1ml of Dongola vaccine containing 
106.2 EID50 by the I/N route, respectively. A4 was left as unvaccinated 
control. All groups were challenged at four weeks post vaccination with 
0.1 ml of Obeid isolate of NDV by the I/M route. Serum samples were 
collected pre-and post vaccination. The Ab response to the vaccine was 
assessed by the HI antibody titre two and four weeks after vaccination.  
2.11.2. Effect of route of administration 
Sixty two-weeks old chicks were divided into four groups of 15 
chicks each. Chicks in group1, 2 and 3 were vaccinated by the I/N, I/O, 
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D/W route, respectively. Chicks in group 4 were left as unvaccinated 
control. 
All groups were challenged at 4 weeks later with 0.1 ml of Obeid isolate 
of NDV by the I/M route. Serum samples were collected pre-and post 
vaccination. The antibody response to the vaccine was assessed by the HI 
antibody titre two and four weeks after vaccination.  
2.11.3. Effect of dose of vaccine 
Seventy-five two-weeks old chicks were divided into five groups of 15 
chicks each. Chicks in group1, 2, 3 and 4 were vaccinated by the I/N route 
with normal dose, half dose, two times and five times normal dose, 
respectively. Chicks in group 5 were left as unvaccinated control. 
All groups were challenged at 4 weeks later with 0.1 ml using Obeid 
isolate of NDV by the I/M route. Serum samples were collected pre-and 
post vaccination. The antibody response to the vaccine was assessed by 
the HI antibody titre two and four weeks after vaccination.  
2.11.4. Comparison between Dongola, K&Lasota vaccines 
Forty two-weeks old chicks were divided into four groups of 10 
chicks each. group1, 2 and 3 were vaccinated by the I/N route with 
Dongola, Lasota and K vaccines, group 4 was left as unvaccinated 
control.  All groups were challenged 4 weeks later by 0.1 ml of Obeid 
isolate of NDV by the I/M route. Serum samples were collected pre-and 
post vaccination. The antibody response to the vaccine was assessed by 
the HI antibody titre two and four weeks after vaccination. 
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                               CHAPTER 3  
RESULTS 
3.1. Master seed 
A volume of 60 ml of the master seed was prepared in embryonated 
eggs. These were divided into 1.5 ml volumes in eppendorf tubes and stored 
at -20 0c. 
3.2. Working seed 
A volume of 100 ml of the working seed was prepared from the 
master seed in embryonated eggs. This was divided into 2 ml volumes in 
eppendorf tubes and stored at -20 0c. The titre of the working seed was found 
to be 109..2 EID50 /ml. 
3.3. The experimental batch of the vaccine  
A volume of 150 ml of the vaccine was prepared from the working 
seed in embryonated eggs. The virus haemagglutinated chicken RBCs in HA 
test to a titre of 10 log2 and its EID50 was found to be 109..2/ml. All 
inoculated embryonated eggs were infected but the virus did not kill the 
embryos. The virus was diluted in PBS to get 106..2/0.1ml/dose. 
Each batch of the vaccine was found to be free from contamination 
with bacteria, fungi and extraneous viruses. 
3.4. Experimental vaccination trials  
3.4.1. Effect of age 
3.4.1.1. One –day old 
Results of the Ab titre and percent protection after challenge of one –
day old chicks vaccinated with Dongola strain by I/N route were shown in 
Table 1, Figure 1 and 14. 
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Table 1: The HI-Ab titre and protection after challenge of one-day old chicks vaccinated with 
Dongola strain by I/N route. 
                                                                                HI titre (log2) 
 
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
 
One-day old(just 
before 
vaccination) 
 
2weeks old(2weeks p.v) 
 
4weeks old(4weeksp.v) 
 
Protection% 
 
Chick 
x HI 
 
Mean±SE 
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
control 
 
1x2 
2x3 
3x4 
4x5 
 
ab 
4±0.33 
 
1x5 
2x2 
3x3 
4x4 
 
ab 
3.4±0.31 
 
2x5 
3x0 
5x2 
 
 
2±0.58 
 
2x4 
1x3 
3x1 
4x2 
 
b 
2.2±0.36 
 
2x1 
3x0 
5x2 
 
 
1.2±o.29 
 
 
30 
 
 
0 
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Fig 1: The HI-Ab titre of one-day old chicks vaccinated with Dongola strain by I/N route  
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The mean HI Ab titre at vaccination and four weeks later were 4 log2 
and 2.2 log2, respectively. The HI titre of control chicks at vaccination and 
four weeks later were 4 log2 and 1.2 log2, respectively. The percent 
protection after challenge in vaccinated chicks and control were 30% and 
0%, respectively. 
3.4.2.1. One- week old 
The mean HI Ab titre at vaccination and four weeks later were 3.3 
log2 and 2.7 log2, respectively. The HI titre of control chicks at vaccination 
and four weeks later were 3.3 log2 and 1.1 log2, respectively. The percent 
protection after challenge in vaccinated chicks and control were 40% and 
0%, respectively as shown in Table 2, Figure 2 and 14.  
3.4.1.3. Two –weeks old 
The mean HI Ab response at vaccination and four weeks later in 
vaccinated chicks and the controls were 2.6 log2, 3.2 log2 and 2.6 log2, 0.9 
log2, respectively. The percent protections after challenge in vaccinated and 
control chicks were 60%, 0%, respectively as shown in Table 3, Figure 3 
and 14. 
Two-week old chicks gave the best Ab titre among the three- groups. 
3.4.2. Effect of route of administration  
3.4.2.1. Drinking water (DW) route 
The mean HI Ab titre and percent protection of two-week old chicks  
vaccinated with Dongola strain by drinking water (DW) route at vaccination 
and after four weeks were 2 log2, 3.6 log2 and control were 2 log2, 1 log2. 
The percent protection in vaccinated chicks and control were 70% and 0%, 
respectively as shown in Table 4, Figure 4 and 12. 
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Table 2: The HI-Ab titre and protection after challenge of one-week old chicks vaccinated with 
Dongola strain by I/N route. 
                                                                                HI titre (log2) 
 
 
 
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
 
 
One-week  
old(just before 
vaccination) 
 
3weeks old(2weeks p.v) 
 
5weeks old(4weeksp.v) 
 
Protection% 
 
Chick 
x HI 
 
Mean±SE 
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
control 
 
1x1 
2x5 
3x2 
4x4 
 
ab 
3.3±0.45 
 
1x7 
2x1 
3x5 
4x4 
 
ab 
4±0.58 
 
2x0 
3x3 
5x2 
 
 
1.9±0.35 
 
1x3 
5x4 
4x1 
 
ab 
2.7±0.47 
 
1x1 
4x0 
5x2 
 
 
1.1±0.31 
 
 
40 
 
 
0 
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Fig 2: The HI-Ab titre of one-week old chicks vaccinated with Dongola strain by I/N route  
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Table 3: The HI-Ab titre and protection after challenge of two-week old chicks vaccinated with 
Dongola strain by I/N route. 
HI titre (log2) 
 
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
 
 
 
 
Two-week  
old(just before 
vaccination) 
 
4weeks old(2weeks p.v) 
 
6weeks old(4weeksp.v) 
 
Protection% 
 
Chick 
x HI 
 
Mean±SE 
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
control 
 
1x2 
5x4 
4x1 
 
ab 
2.6±0.48 
 
1x1 
5x4 
4x6 
 
a 
4.5±0.50 
 
2x1 
3x0 
5x2 
 
 
1.2±0.29 
 
2x1 
3x5 
5x3 
 
 
3.2±0.47 
 
1x1 
4x2 
5x0 
 
 
0.9±.031 
 
 
60 
 
 
0 
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Fig 3 : The HI-Ab titre of two-weeks old chicks vaccinated with Dongola strain by I/N route  
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Table 4: The HI -Ab titre and protection after challenge of two-weeks-old chicks vaccinated 
with Dongola strain by Drinking water (DW) route.  
 
                                                                                HI titre (log2) 
 
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
 
2weeks old(just 
before 
vaccination) 
 
4weeks old (2 weeks p.v) 
 
6weeks old(4weeks p.v) 
 
Protection% 
 
Chick 
x HI 
 
Mean±SE 
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
control 
 
3x2 
3x3 
1x5 
3x0 
 
b 
2±0.52  
 
2x5 
4x6 
2x7 
3x3 
1x2 
 
   a 
4.9±0.50 
 
2x2 
4x3 
6x0 
 
 
1.3±0.41 
 
1x5 
2x2 
5x4 
   a 
3.6±0.38 
 
1x2 
2x3 
5x0 
 
 
1±0.50 
 
 
70 
 
 
0 
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Fig 4 : The HI-Ab titre of two-weeks old chicks vaccinated with Dongola strain by DW route
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3.4.2.2. Intranasal (I/N) route 
The mean HI Ab titre in vaccinated chicks at vaccination and four 
weeks later were 2.2 log2 and 4 log2, respectively. The HI titre of control 
chicks at vaccination and four weeks later were 2.2 log2 and 1 log2, 
respectively. The percent protection after challenge in vaccinated chicks and 
control were 80% and 0%, respectively as shown in Table 5, Figure 5 and 
12.  
3.4.2.3. Intraocular (I/O) route 
The mean HI Ab titre in vaccinated chicks at vaccination and four 
weeks later were 2.7 log2 and 4.1 log2, respectively. The HI titre of control 
chicks at vaccination and four weeks later were 2.7 log2 and 1 log2, 
respectively. The percent protection after challenge in vaccinated chicks and 
control were 85% and 0%, respectively as shown in Table 6, Figure 6 and 
12.  
Intraocular route induced higher Ab titre more than DW, I/N routes. 
3.4.3. Effect of dose of vaccine 
3.4.3.1. Half the recommended dose 
Results of HI Ab titre and percent protection after challenge of two-
weeks old chicks vaccinated with Dongola strain by I/N route using half the 
recommended dose were shown in Table 7, Figure 7 and 15.  
The mean HI Ab titre at vaccination and four weeks later were 2.3 log2 and 
2.4 log2, respectively. The HI titre of control chicks at vaccination and four 
weeks later were 2.3 log2 and 1 log2, respectively. 
The percent protection after challenge in vaccinated chicks and control were 
30% and 0%, respectively. 
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Table 5: The HI –Ab titre and protection after challenge of two-weeks-old chicks vaccinated 
with Dongola strain by Intranasal (I/N) route. 
                                                                                HI titre (log2) 
 
**Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
 
 
 
2weeks old (just 
before  
vaccination) 
 
4weeks old(2weeks p.v) 
 
6weeks old(4weeksp.v) 
 
Protection% 
 
Chick 
x HI 
 
Mean±SE 
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
control 
 
2x1 
2x4 
6x2 
 
b 
2.2±0.33 
 
2x3 
1x4 
4x5 
5x6 
 
a 
5±0.33 
 
2x2 
4x3 
6x0 
 
 
1.3±0.41 
 
1x7 
3x3 
4x4 
 
a 
4±0.46 
 
1x2 
2x3 
5x0 
 
 
1±0.50 
 
 
80 
 
 
0 
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Fig 5 : The HI-Ab titre of two-weeks old chicks vaccinated with Dongola strain by I/N route
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Table 6: The HI –Ab titre and protection after challenge of two-weeks-old chicks vaccinated 
with Dongola strain by Intra ocular(I/O) route. 
                                                                                HI titre (log2) 
 
 
 
2weeks old (just 
before 
vaccination) 
 
4weeks old(2weeks p.v) 
 
6weeks old(4weeksp.v) 
 
Protection% 
 
Chick 
xHI 
 
Mean±SE 
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
control 
 
2x5 
7x2 
1x3 
 
 
b 
2.7±o.40 
 
2x5 
3x6 
4x3 
2x7 
1x8 
 
a 
5.2±0.52 
 
2x2 
4x3 
6x0 
 
 
1.3±o.41 
 
1x3 
2x5 
5x4 
 
a 
4.1±o.23 
 
1x2 
2x3 
5x0 
 
 
1±0.50 
 
 
85 
 
 
0 
 
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
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Fig 6 : The HI-Ab titre of two-weeks old chicks vaccinated with Dongola strain by I/O route
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Table 7: The HI-Ab titre and protection after challenge of two-weeks-old chicks vaccinated  
with Dongola strain by I/N using half the recommended dose. 
 
                                                                                HI titre (log2) 
 
 
 
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
 
 
2weeks-old (just 
before 
vaccination) 
 
4weeks old(2weeks p.v) 
 
6weeks old(4weeks p.v) 
 
Protection% 
 
Chick 
x HI 
 
Mean±SE 
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
control 
 
5x2 
4x3 
1x1 
 
a 
2.3±0.21 
 
2x5 
1x7 
3x4 
6x2 
 
a 
3.4±0.48 
 
2x2 
4x3 
6x0 
 
 
1.3±0.41 
 
1x1 
2x4 
5x2 
 
a 
2.4±0.38 
 
1x2 
2x3 
5x0 
 
 
1±0.50 
 
 
30 
 
 
0 
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Fig 7 : The HI-Ab titre of two-weeks old chicks vaccinated with Dongola strain by I/N route using half the recommended 
dose
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3.4.3.2. The recommended dose 
The mean HI Ab titre at vaccination and four weeks later were 2.4 
log2 and 2.9 log2, respectively. The HI titre of control chicks at vaccination 
and four weeks later were 2.4 log2 and 1 log2, respectively. The percent 
protection after challenge in vaccinated chicks and control were 50% and 
0%,respectively as shown in Table 8, Figure 8 and 13. 
3.4.3.3. Twice the recommended dose 
The mean HI Ab response at vaccination and four weeks later in 
vaccinated chicks and control were 1.9 log2, 3.4 log2 and 1.9 log2, 1 log2, 
respectively. The percent protection after challenge was 70% and  0%, 
respectively as shown in Table 9, Figure 9 and 13. 
3.4.3.4. Five times the recommended dose 
The mean HI Ab response at vaccination and four weeks later in 
vaccinated chicks and control were 1.7 log2, 3.4 log2 and 1.7 log2, 1 log2, 
respectively and percent protections after challenge were 70%, 0%, 
respectively as shown in Table 10, Figure 10 and 13. 
 
3.4.4. Comparison between Dongola, K, Lasota strain 
3.4.4.1. Lasota strain 
Results of HI Ab titre and percent protection after challenge of two-
weeks old chicks vaccinated with Lasota strain by I/N route were shown in 
Table 11, Figure 11 and 15. The mean HI Ab response at vaccination and 
four weeks later in vaccinated chicks and control were 2.9 log2, 1.8 log2 and 
2.9 log2, 1 log2, respectively and the percent protections after challenge were 
20%, 0%, respectively. 
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Table 8: The HI-Ab titre and protection after challenge of two-weeks-old chicks vaccinated 
with Dongola strain by I/N using the recommended dose. 
                                                                                HI titre (log2) 
 
 
 
 
 
 
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
 
 
 
 
 
1x3 
2x5 
4x3 
3x1 
 
b 
2.4±0.47 
 
3x6 
4x3 
5x5 
 
a 
4.6±0.36 
 
2x2 
4x3 
6x0 
 
 
1.3±0.41 
 
1x4 
2x2 
5x3 
 
b 
2.9±0.23 
 
1x2 
2x3 
5x0 
 
 
1±0.50 
 
 
50 
 
 
0 
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Fig 8 : The HI-Ab titre of two-weeks old chicks vaccinated with Dongola strain by I/N route using the recommended 
dose
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Table 9: The HI-Ab titre and protection after challenge of two-weeks-old chicks vaccinated 
with Dongola strain by I/N using twice the recommended dose. 
                                                                                HI titre (log2) 
 
 
                    
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
 
 
2weeks-old (just 
before 
vaccination) 
 
4weeks old(2weeks p.v) 
 
6weeks old(4weeks p.v) 
 
Protection% 
 
Chick 
x HI 
 
Mean±SE 
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
control 
 
5x1 
4x3 
1x2 
 
c 
1.9±0.31 
 
2x3 
4x6 
5x4 
1x7 
 
a 
4.8±0.39 
 
2x2 
4x3 
6x0 
 
 
1.3±0.41 
 
1x1 
3x2 
4x5 
 
b 
3.4±0.63 
 
1x2 
2x3 
5x0 
 
 
1±0.50 
 
 
70 
 
 
0 
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Fig 9 : The HI-Ab titre of two-weeks old chicks vaccinated with Dongola strain by I/N route using twice the 
recommended dose
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Table 10: The HI-Ab titre and protection after challenge of two-weeks-old chicks vaccinated 
with Dongola strain by I/N using five times the recommended dose. 
 
                                                                                HI titre (log2) 
 
 
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
 
2weeks-old (just 
before 
vaccination) 
 
4weeks old(2weeks p.v) 
 
6weeks old(4weeks p.v) 
 
Protection% 
 
Chick 
x HI 
 
Mean±SE 
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
Mean±SE
 
control
 
Mean±SE
 
Vaccinated 
chicks 
 
control 
 
3x3 
3x2 
2x1 
2x0 
 
c 
1.7±0.37 
 
1x5 
2x6 
3x4 
6x8 
 
a 
6.4±0.51 
 
2x2 
4x3 
6x0 
 
 
1.3±0.41 
 
1x2 
3x3 
4x4 
 
b 
3.4±0.26 
 
1x2 
2x3 
5x0 
 
 
1±0.50 
 
 
70 
 
 
0 
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Fig 10 : The HI-Ab titre of two-weeks old chicks vaccinated with Dongola strain by I/N route using five times the 
recommended dose
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3.4.4.2. Dongola strain  
The mean HI Ab response at vaccination and four weeks later in 
vaccinated chicks and control were 3.1 log2, 2.8 log2 and 3.1 log2, 0.9 log2, 
respectively and percent protections after challenge were 50%, 0%, 
respectively as shown in Table 11, Figure 11 and 15. 
3.4.4.3. K strain 
The mean HI Ab titre in vaccinated chicks at vaccination and four 
weeks later were 2.7 log2 and 3.9 log2, respectively. The control was 2.7 log2 
and 0.9 log2, respectively. The percent protection after challenge in 
vaccinated chicks and control were 80% and 0%, respectively as shown in 
Table 11, Figure 11 and 15. 
 K strain induced the best immune response in comparison to Lasota 
strain, Dongola strain. 
Results were analyzed by the SAS system.  
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Table 11: The HI-Ab titre and protection after challenge of two-week old chicks vaccinated 
with Lasota, Dongola, and K strain by I /N route. 
                                                                                HI titre (log2) 
 
*Means (±SE) with the same letters in each column are not significantly different at 5% level according to Rayan 
Q test. 
*SE= Stander error. 
 
2 weeks old(just 
before 
vaccination) 
 4weeks old(2weeks p.v) 6weeks old(4 weeks p.v) Protection% Vaccine 
strain 
Chick 
x HI 
Mean±SE Vaccinated 
chicks 
Mean±SE control Mean±SE Vaccinated 
chicks 
Mean±SE control Mean±SE Vaccinated 
chicks 
control
Lasota 2x5 
3x3 
5x2 
a 
2.9±0.38 
1x5 
2x1 
3x4 
4x3 
a 
3.1±0.41 
2x1 
3x0 
5x2 
 
1.2±0.29 
2x2 
3x3 
5x1 
b 
1.8±0.29 
1x1 
4x2 
5x0 
 
0.9±0.31 
 
20 
 
0 
Dongola 1x5 
2x1 
3x4 
4x3 
b 
3.1±0.41 
1x2 
4x6 
5x4 
a 
4.6±0.43 
2x1 
3x0 
5x2 
 
 
1.2±0.29 
1x1 
2x5 
3x3 
4x2 
b 
2.8±0.42 
1x1 
4x2 
5x0 
 
0.9±0.31 
 
50 
 
0 
K 1x3 
5x4 
4x1 
c 
2.7±0.47 
1x6 
2x5 
3x4 
4x7 
a 
5.6±0.43 
2x1 
3x0 
5x2 
 
 
1.2±0.29 
1x4 
5x3 
4x5 
b 
3.9±0.31 
1x1 
4x2 
5x0 
 
0.9±0.31 
 
80 
 
0 
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Fig 11: The HI-Ab titre of two-weeks old chicks vaccinated with Lasota, Dongola and K 
strains by I/N route
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Fig 12 : The protection% after challenge of two-weeks old chicks vaccinated with Dongola strain by DW, I/N& I/O route
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Fig 13 : The protection% after challenge of two-weeks old chicks vaccinated with Dongola strain by I/N route using 
different doses
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Fig 14 : The protection% after challenge of one-day, one-week &two-weeks old chicks vaccinated with Dongola strain by 
I/N route .
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Fig 15 : The protection% after challenge of two-weeks old chicks vaccinated with Dongola, Lasota & K strain by I/N route .
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CHAPTER 4 
DISCUSSION 
 
Newcastle disease virus strains and isolates are generally considered 
to form an antigenically homologous group. This concept is fundamental in 
the vaccination procedures for poultry. Lancaster (1966) showed that the 
development of immunity in response to vaccination is influenced by 
number of factors. The most important factors are the age and the amount of 
maternal immunity at the time of vaccination.  
When devising a vaccination programme, consideration should be 
given to the type of vaccine used, the immune and the disease status of the 
birds, and the level of protection required in relation to any possibility of 
infection with field virus under local condition (Allan et al., 1978). 
In the present study, the immunogenicity of a local lentogenic NDV 
isolate was tested. This strain was isolated from apparently healthy chickens 
at Dongola city of northern Sudan in 1988 (Khalafalla, 1994). Additionally, 
this study aimed at determining the effect of route of administration of the 
vaccine virus, the age of chickens at vaccination and the dose of vaccine on 
the antibody response to NDV Dongola vaccine as detected by HI test and 
percent protection after challenge with virulent virus. This study was also 
aimed at comparing Dongola strain with two ND vaccines namely Komarov 
and Lasota which are commonly used in the Sudan for the control of ND.  
The master seed and working seed of the Dongola vaccine were 
prepared by passages in embryonated eggs. This isolate grew readily to high 
titre in embryonated eggs. This isolate is not lethal to chick embryo since all 
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inoculated embryos remained alive till day 5 post inoculation. The 50% 
infectivity in embryonated eggs (EID50) of the vaccine was determined and 
found to be 109.2/ml. The prepared vaccine was found to be free from viral, 
bacterial, mycoplasmal and fungal contamination. Accordingly, this isolate 
of NDV could be a good candidate for vaccine production in embryonated 
eggs. 
In the present study, the potency of Dongola strain was compared with 
two ND vaccines namely Komarov and Lasota. Dongola strain induced a 
good immune response (mean of 4.6 log 2 two weeks post vaccination) and 
percent protection (50%) better than Lasota (mean of 3.1 log2 two weeks 
post vaccination) and percent protection (20%) but less than Komarov strain.  
Previous reports have showed the higher immunogencity of komarov strain 
of NDV. Zakia et al reported that re-vaccination of chicks with K strain, 
initially vaccinated with F strain resulted in increase of the mean HI titre. 
This is probably due to the combined effect of the compatibility of the 
immune system and the mesogenic nature of the vaccine virus which 
reduced interference between the residual antibody and the vaccine virus.     
Reeve et al (1974) reported that the immune response increases as the 
pathogenicity of the live virus vaccine increases.  
Beaudette et al (1949) pointed out that chickens less than 8 weeks of 
age should not be vaccinated with mesogenic strains because of vaccine 
reaction. However, the K strain induced no clinical reaction when 
administered to day-old chicks (Haroun and Hajer, 1989). 
The results obtained showed that vaccination of one –day and one-
week old chicks having high level of maternally derived antibodies (MDA) 
with Dongola strain by I/N route resulted in a remarkable decrease of 
antibodies as detected by HI (Table 1, 2). This is due to interference of 
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MDA with the immune response to achieve vaccination at early age. This 
finding agrees with that of Mahasin et al (1980) who reported that 
vaccination of chicks having high levels of maternal HI antibodies resulted 
in a decreased of the mean HI antibody titres in the one-day and one-week 
old chicks which had high titres at the time of vaccination. Maternal 
antibodies may not always be protective against natural infection even in 
moderate to high titre (Allan, 1973; Parry and Aitken, 1977). Haroun and 
Hajer (1989) showed that chickens with a maternal antibody titre of 23.5 died 
on challenge.     
Two weeks old chicks with low MDA developed, in the present study, 
high HI titre. This point to the relationship between the pre-and post 
vaccination titre and indicated the in vivo neutralization of vaccine virus due 
to the presence of maternal antibodies. This result agreed with Westbury et 
al (1984) and Haroun and Hajer (1989). 
The increased use of living viral vaccines has given more importance 
to the influence of the routes of administration on their effectiveness. In this 
study chickens of two weeks old were vaccinated by DW, I/N and I/O route. 
The results showed that the I/O route gave high HI titre and good protection 
after challenge. Chicks vaccinated by I/N route showed higher HI titre than 
those vaccinated by DW route. This finding agrees with Kheir (1992) who 
found that vaccination of five-weeks old chicks with K strain by I/N route 
induced greater HI titre than those vaccinated by DW route. Our finding also 
agreed with Gaffar Elamin et al (1993) who reported that vaccination of 
broilers with K strain by nasal drops or intramuscularly stimulated a 
protective immune response against a standard ND challenge, whereas the 
same vaccine given by spray or the oral route did not. 
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 The incorporation of live NDV vaccine in DW is cheap and easy for 
mass vaccination but the method is not very effective.  
Use of different doses of Dongola strain by I/N route was tried in this 
study. Vaccination of chicks with Dongola strain using half the 
recommended dose resulted in low HI titre and low protection. However, 
using of the recommended dose, twice and five times the recommended dose 
resulted in increased HI titre and protection with no adverse vaccination 
reactions among vaccinated chicks which looked normal and healthy 
throughout the experimental time. This proves that Dongola vaccine is 
absolutely safe. 
From the findings of the present study it is concluded that: 
1- Dongola strain is a potentially good vaccine candidate against ND. 
2- This virus grew well in embryonated eggs and yield high virus titre. 
3- This virus Induce good immune response. As measured by HI 
antibody titre and protection of vaccinated chicks. 
4- The immune response induced by Dongola strain is comparable to 
Lasota and Komarov vaccines. 
5- The vaccine produced from Dongola strain is safe to chicks at early 
age and in high doses.  
It is therefore, recommended to produce a vaccine from Dongola strain in 
embryonated eggs to be used via intraocular route at the age of two weeks in 
the Sudan. Further research should focus in designing a vaccination program 
that includes Dongola strain as a prime vaccine followed by K strain. 
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APPENDICES 
 
1. Physiological normal saline (NS) 
Nacl                                                  8.5 gm 
DDW                                                1000 ml 
The mixture was autoclaved at 1150c for 10 minutes. 
2. Phosphate buffer saline solution (PBS) 2 litres 
     Solution (a) 
      Nacl                                                       16.0 gm  
      KCl                                                         0.4 gm 
     Na2 HPO4 (anhydrous)                            0.4 gm 
     DDW completed to                                 1500 ml 
   Solution (b) 
     Mg cl2 6 H2O (hydrous)                           0.426 gm 
     DDW complete to                                     200 ml 
  Solution (c) 
     Cacl2 (hydrous)                                         0.264 gm 
     DDW complete to                                     200 ml 
    Solution (a), (b) and (c) were autoclaved and left to cool. 
To prepare working solution of PBS solution (a) and (b) were mixed. 
Solution (c) was then added and the final volume was brought to 2 liters 
with sterile DDW. 
3. Al sever ۥs solution (anticoagulent) 
    D-glucose or dextrose                                20.5 gm 
    Nacl                                                            4.2 gm 
    Na citrate                                                    8.0 gm 
    Citric acid                                                  0.55 gm 
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The mixture was completed to one liter with DDW and autoclaved at 1150c 
for 10 minutes. 
4. Working solutions of Antibiotics 
      Antibiotics were used to control bacterial contamination in suspensions 
prepared for chick embryo inoculation. 
Penicillin stock solution (105/ml)                   2.0 ml 
Streptomycin stock solution (105/ml)             2.0 ml 
PBS                                                                 46.0 ml 
Total                                                               50 ml                                                  
 
     
 
 
 
